PerkinElmer Announces Finance Leadership Transition
Max Krakowiak has been appointed as the new Chief Financial Officer of PerkinElmer (NYSE:PKI), succeeding Jamey Mock, who is leaving for another opportunity. The transition is effective as of September 6, 2022. Krakowiak has been with PerkinElmer for four years, serving as the Vice President of Corporate Finance and has led key financial initiatives. The company reaffirms its financial guidance provided on August 1, 2022. CEO Prahlad Singh expressed confidence in Krakowiak's capabilities and acknowledged Mock's contributions during his tenure.
- Appointment of Max Krakowiak as CFO expected to bring fresh leadership and continuity in financial strategy.
- Krakowiak's prior experience within the company may accelerate ongoing financial transformation efforts.
- Transition of Jamey Mock may create temporary disruption during the leadership change.
- Uncertainty surrounding the future direction post-transition may raise concerns among investors.
“I would like to thank Jamey for the significant impact he’s had on making PerkinElmer’s goals come to fruition the past several years,” said
Singh added, “I am pleased to appoint Max as CFO. I have worked closely with him over the last four years as he has played an integral role on the finance leadership team and was a key project leader in our recently announced divestiture. I am confident in Max’s future contributions as we move ahead in an exciting new chapter for the Company.”
Krakowiak has served as PerkinElmer’s finance chief of staff, focusing on driving global finance transformation through people, process and automation. He brings experience across global financial planning and analysis, commercial finance and business development. Prior to PerkinElmer, Krakowiak worked for
“Reflecting on my time at PerkinElmer, I am extremely proud to have been part of a talented team that was able to accomplish such a significant transformation of both our portfolio and financial profile, ” said Mock. “I look forward to following the Company’s future successes, and I know that Max will bring valuable expertise as he steps into the role.”
The Company is also reaffirming its financial guidance that was last provided on
About PerkinElmer
PerkinElmer is a leading, global provider of end-to-end solutions that help scientists, researchers and clinicians better diagnose disease, discover new and more personalized drugs, monitor the safety and quality of our food, and drive environmental and applied analysis excellence. With an 85-year legacy of advancing science and a mission of innovating for a healthier world, our dedicated team of more than 16,000 collaborates closely with commercial, government, academic and healthcare customers to deliver reagents, assays, instruments, automation, informatics and strategic services that accelerate workflows, deliver actionable insights and support improved decision making. We are also deeply committed to good corporate citizenship through our dynamic ESG and sustainability programs. The Company reported revenues of approximately
View source version on businesswire.com: https://www.businesswire.com/news/home/20220817005109/en/
Investor Relations:
(781) 663-5677
steve.willoughby@perkinelmer.com
Media Relations:
(781) 663-5719
chet.murray@perkinelmer.com
Source:
FAQ
Who is the new CFO of PerkinElmer (PKI)?
Why did Jamey Mock leave PerkinElmer?
When did Max Krakowiak become CFO of PerkinElmer?
What is the background of Max Krakowiak?